Dr. Beth Beadle's group's research goals are to improve the outcomes of patients diagnosed with head and neck cancer through the integration of novel agents with radiation therapy, understanding key molecular drivers of the disease, and optimizing the use of advanced computational and physics-based approaches to improve treatment planning. Given the growing global impact of cancer, Dr. Beadle has a special interest in understanding similarities and differences in the head and neck cancers that develop around the world, with a goal of bringing reliable, high-quality radiation therapy to low- and middle-income countries.